Tute Genomics Gets $2.3M For Personalized Medicine

Provo, Utah-based Tute Genomics said Thursday that it has raised $2.3M in a Series A1 funding, which was led by Eurovesttech, a UK-based investment company. Peak Ventures and angels also participated in the funding. Tute Genomics, which is led by Reid Robison, is develop a cloud-based, genome analytics software platform. The company says it is looking to help accelerate personalized medicine.